LPL Financial’s Acceleron Pharma XLRN Stock Holding History

LPL Financial’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,412	Closed	-$1.1M	–	4529
2021 Q3	$1.1M	Buy	6,412 +2,741	+75%	+$359K	﹤0.01%	2531
2021 Q2	$461K	Sell	3,671 -53	-1%	-$6.68K	﹤0.01%	3234
2021 Q1	$505K	Buy	3,724 +1,399	+60%	+$181K	﹤0.01%	3015
2020 Q4	$297K	Buy	2,325 +157	+7%	+$18.4K	﹤0.01%	3205
2020 Q3	$244K	Sell	2,168 -1,547	-42%	-$154K	﹤0.01%	3051
2020 Q2	$354K	Buy	+3,715	New	+$358K	﹤0.01%	2707

LPL Financial's XLRN Position: Q4 2021 in Review

LPL Financial sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,412 shares — an estimated $1.1M sold.

LPL Financial first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $1.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

LPL Financial reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
LPL Financial sold 6,412 Acceleron Pharma shares in Q4 2021, an estimated $1.1M.
LPL Financial first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
LPL Financial's Acceleron Pharma position peaked at $1.1M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on LPL Financial's 13F filing for Q4 2021, filed 14 Feb 2022.